Yatham L N, Kusumakar V, Parikh S V, Haslam D R, Matte R, Sharma V, Kennedy S
Department of Psychiatry, University of British Columbia, Vancouver.
Can J Psychiatry. 1997 Aug;42 Suppl 2:87S-91S.
To review studies on treatments for bipolar depression and make recommendations for practising clinicians treating patients with bipolar depression.
Studies that examined various treatments for bipolar depression were evaluated and rated for evidence of efficacy using Periodic Health Examination criteria. The rating for classification of recommendation for an intervention was made taking both the efficacy and the side effects into consideration.
Mood stabilizers, cyclic antidepressants, monoamine oxidase inhibitors (MAOIs), and electroconvulsive therapy (ECT) are all effective in treating bipolar depression. Almost all antidepressant treatments with the exception of mood stabilizers have been reported to induce a manic-hypomanic switch and rapid cycling.
Mood stabilizers, lithium in particular, are recommended as the first-line treatment. Addition of a second mood stabilizer or a cyclic antidepressant would be an appropriate next step. Newer agents such as lamotrigine offer considerable promise in treating bipolar depressed patients.
回顾双相抑郁治疗的相关研究,并为治疗双相抑郁患者的临床医生提供建议。
评估检验双相抑郁各种治疗方法的研究,并根据定期健康检查标准对疗效证据进行评级。在考虑疗效和副作用的基础上,对干预措施的推荐分类进行评级。
心境稳定剂、环性抗抑郁药、单胺氧化酶抑制剂(MAOIs)和电休克治疗(ECT)在治疗双相抑郁方面均有效。除心境稳定剂外,几乎所有抗抑郁治疗均有诱发躁狂-轻躁狂发作转换和快速循环的报道。
推荐心境稳定剂,尤其是锂盐作为一线治疗。下一步适当的做法是加用第二种心境稳定剂或环性抗抑郁药。新型药物如拉莫三嗪在治疗双相抑郁患者方面前景可观。